Versant Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.3K | Buy |
624
+268
| +75% | +$6.15K | ﹤0.01% | 1708 |
|
2025
Q1 | $10.3K | Buy |
356
+135
| +61% | +$3.91K | ﹤0.01% | 1714 |
|
2024
Q4 | $8.21K | Sell |
221
-47
| -18% | -$1.75K | ﹤0.01% | 1514 |
|
2024
Q3 | $13K | Hold |
268
| – | – | ﹤0.01% | 966 |
|
2024
Q2 | $10.7K | Hold |
268
| – | – | ﹤0.01% | 956 |
|
2024
Q1 | $11.8K | Hold |
268
| – | – | ﹤0.01% | 711 |
|
2023
Q4 | $16.6K | Sell |
268
-98
| -27% | -$6.06K | ﹤0.01% | 557 |
|
2023
Q3 | $16.8K | Sell |
366
-60
| -14% | -$2.76K | 0.01% | 538 |
|
2023
Q2 | $24.5K | Sell |
426
-30
| -7% | -$1.72K | 0.01% | 441 |
|
2023
Q1 | $17.1K | Sell |
456
-18
| -4% | -$676 | 0.01% | 539 |
|
2022
Q4 | $13.3K | Hold |
474
| – | – | ﹤0.01% | 591 |
|
2022
Q3 | $13K | Sell |
474
-1
| -0.2% | -$27 | 0.01% | 558 |
|
2022
Q2 | $17K | Sell |
475
-41
| -8% | -$1.47K | 0.01% | 469 |
|
2022
Q1 | $19K | Sell |
516
-48
| -9% | -$1.77K | 0.01% | 476 |
|
2021
Q4 | $13K | Buy |
564
+61
| +12% | +$1.41K | ﹤0.01% | 629 |
|
2021
Q3 | $10K | Sell |
503
-46
| -8% | -$915 | ﹤0.01% | 686 |
|
2021
Q2 | $11K | Buy |
549
+76
| +16% | +$1.52K | ﹤0.01% | 671 |
|
2021
Q1 | $9K | Hold |
473
| – | – | ﹤0.01% | 805 |
|
2020
Q4 | $9K | Hold |
473
| – | – | ﹤0.01% | 743 |
|
2020
Q3 | $8K | Hold |
473
| – | – | ﹤0.01% | 718 |
|
2020
Q2 | $10K | Buy |
473
+10
| +2% | +$211 | ﹤0.01% | 614 |
|
2020
Q1 | $6K | Buy |
+463
| New | +$6K | ﹤0.01% | 692 |
|
2019
Q1 | – | Sell |
-22
| Closed | – | – | 1543 |
|
2018
Q4 | $0 | Buy |
22
+10
| +83% | – | ﹤0.01% | 1461 |
|
2018
Q3 | $0 | Sell |
12
-3
| -20% | – | ﹤0.01% | 1506 |
|
2018
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 1496 |
|
2018
Q1 | $0 | Sell |
15
-28
| -65% | – | ﹤0.01% | 1474 |
|
2017
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 1517 |
|
2017
Q3 | $0 | Sell |
43
-187
| -81% | – | ﹤0.01% | 1433 |
|
2017
Q2 | $4K | Buy |
+230
| New | +$4K | ﹤0.01% | 1084 |
|